73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G

Blocking pro-fibrosis pathway may improve immunotherapy of metastatic breast cancer

by Massachusetts General HospitalMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaA Massachusetts G
New compounds target and kill brain cancer cells after being energized by low X-ray dose

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound

New compounds target and kill brain cancer cells after being energized by low X-ray dose

by Nanyang Technological UniversityResearch fellow Dr Huang Jingsheng from NTU Singapore's School of Chemistry, Chemical Engineering and Biotechnology preparing new anti-brain cancer compound
Accurate assessment of heart rhythm can optimize chemotherapy use

Accurate assessment of heart rhythm can optimize chemotherapy use

byUNC Lineberger Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainUsing the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-sa

Accurate assessment of heart rhythm can optimize chemotherapy use

byUNC Lineberger Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainUsing the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-sa
Discovery suggests which thyroid cancer patients may need more aggressive treatment

Discovery suggests which thyroid cancer patients may need more aggressive treatment

by Ross Neitz,University of AlbertaOncology professor and surgeon Todd McMullen (right) says the study will help surgeons determine which patients will benefit from less aggressive treatment and

Discovery suggests which thyroid cancer patients may need more aggressive treatment

by Ross Neitz,University of AlbertaOncology professor and surgeon Todd McMullen (right) says the study will help surgeons determine which patients will benefit from less aggressive treatment and
Novel classification can lead to new ways to diagnose and treat cancer

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0
Team targets tumor suppressor to treat 'triple-negative' breast cancer

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc

Team targets tumor suppressor to treat 'triple-negative' breast cancer

by University of Arizona Health SciencesAgnieszka Witkiewicz, MD and Erik Knudsen, PhD, UA Cancer Center. Credit: BioCommunications, Kris HanningA study by scientists at the University of Arizona Canc
Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC

Ibrutinib and venetoclax combo effective as front-line therapy for select chronic lymphocytic leukemia patients

by University of Texas M. D. Anderson Cancer CenterA Wright's stained bone marrow aspirate smear of patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/Wikimedia/CC
Study refines understanding of T cells' action in HIV immune response

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m

Study refines understanding of T cells' action in HIV immune response

by Los Alamos National LaboratoryThe effect of M-T807R1 administration and RAL monotherapy on blood CD8+T cell dynamics. The effects of M-T807R1 on the dynamics of CD8 cells in individual m
Potential new series of drugs targeting cancer-driving protein BCL6

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /

Potential new series of drugs targeting cancer-driving protein BCL6

byInstitute of Cancer ResearchThe BCL6 BTB domain dimer (in grey/green) and compound hits in pink, superimposed on each other in the main compound binding site. Credit: Dr Rob van Montfort lab /
Researchers look to the gut to boost cancer immunotherapy's fighting power

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie
Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H

Researchers discover molecular fail-safe that keeps bladder tissues from turning cancerous

by Fred Hutchinson Cancer CenterCredit: Pixabay/CC0 Public DomainOver the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred H